| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 38,405 | 37,124 | 40,972 | 47,324 | | Cost of Revenue | 7,580 | 9,674 | 9,958 | 10,238 | | | Gross Profit | 30,825 | 27,450 | 31,014 | 37,086 | | | Operating Expenses | | Research Development | 11,443 | 11,866 | 12,185 | 12,483 | | Selling General and Administrative | 19,872 | 20,623 | 22,467 | 21,000 | | Non Recurring | 3,533 |
-
|
-
|
-
| | Others | 2,551 | 160 | 217 | 201 | | | | Total Operating Expenses | 37,399 |
-
|
-
|
-
| | | | Operating Income or Loss | (6,574) | (5,199) | (3,855) | 3,402 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 668 | (844) | (15,309) | (2,893) | | Earnings Before Interest And Taxes | (5,906) | (6,043) | (19,164) | 509 | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (5,906) | (6,043) | (19,164) | 509 | | Income Tax Expense | (3,252) | (2,052) | (899) | 26 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (2,654) | (3,991) | (18,265) | 483 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (2,654) | (3,991) | (18,265) | 483 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($2,654) | ($3,991) | ($18,265) | $483 |
|
0.31% Nasdaq 0.00%
Income Statement
